What is Spravato?
Spravato® (esketamine) is the first nasal spray medication specifically for adults with treatment-resistant depression.
If you’ve tried two or more antidepressants and are still struggling with depressive symptoms, talk to your healthcare provider to see if you may have treatment-resistant depression.
Symptoms associated with major depressive disorder may include:
- Depressed mood or feelings of sadness
- Disrupted sleep
- Lack of interest or inability to feel pleasure
- Feelings of guilt or hopelessness
- Lack of energy
- Difficulty concentrating
- Change in appetite or weight
- Slowed thoughts or movements
- Restlessness and/or purposeless movements
- Suicidal thoughts or actions
Spravato Enrollment Information Requirements
It is mandatory to have a direct referral from a mental health provider before being considered for treatment with Spravato®. Your mental health provider may call (865) 401-9242 to refer you directly.
Once the referral has been received it is then necessary for the patient to schedule a consultation with a provider at Revitalist. This will be a comprehensive consultation that will include completion of the Patient Enrollment form if all criteria for candidacy are met.
Patients must be enrolled in the SPRAVATO™ REMS in order to receive SPRAVATO®. Go to the link below and download the Patient Enrollment Form:
SPRAVATO® REMS Patient Enrollment Form: https://spravatorems.com/outpatient-hcs.html
For additional patient information on SPRAVATO® visit: https://www.spravatorems.com/patients